Blanco E, Galvez R, Zamorano E, López V, Pérez M
Centro de Salud de Béjar, Salamanca, España.
Semergen. 2012 May-Jun;38(4):203-10. doi: 10.1016/j.semerg.2011.10.012. Epub 2011 Dec 21.
Primary Care Physicians are usually the first to see patients with neuropathic pain. The aim of this study is to assess the prevalence of neuropathic pain, its therapeutic management, and to clinically characterize these patients.
An epidemiological, observational, cross-sectional study was carried out in Spanish Primary Care settings. The first 25 patients older than 18 years with any type of pain (a total of 16,115) were registered, and the first 5 with a high neuropathic pain component according to the NP4 test, and was clinically confirmed (n= 3,836) were included in the study. Pain intensity and impact on daily activities, as well as overall satisfaction with treatment were assessed.
A total of 45.7% of patients had neuropathic pain according to NP4 test. The median age was 59 years, and 60% were women. Patients took a mean of 2.4 drugs, with NSAIDs (53%) and non-opioid analgesics (51%) being the most common. The scores for Pain intensity and interference in daily activities were both 6.2. The overall opinion of the SATMED-Q test was 47.3/100, which was 1.4 points lower than the standardised score according to Spanish population.
Neuropathic pain according to NP4 test is highly prevalent in Spanish Primary Care settings. The management of these patients with NSAIDs and non-opioid analgesics is not appropriate, as they are not recommended for this kind of pain. Although they were being treated with more than 2 analgesics, they still referred to high pain intensity, interference in daily activities, and a low general opinion of the treatment.
基层医疗医生通常是首批诊治神经性疼痛患者的医生。本研究旨在评估神经性疼痛的患病率、治疗管理情况，并对这些患者进行临床特征描述。
在西班牙基层医疗环境中开展了一项流行病学、观察性横断面研究。登记了首批25名年龄超过18岁且患有任何类型疼痛的患者（共16115名），并纳入了首批5名根据NP4测试具有高度神经性疼痛成分且经临床确诊的患者（n = 3836）。评估了疼痛强度、对日常活动的影响以及对治疗的总体满意度。
根据NP4测试，共有45.7%的患者患有神经性疼痛。中位年龄为59岁，60%为女性。患者平均服用2.4种药物，其中非甾体抗炎药（53%）和非阿片类镇痛药（51%）最为常见。疼痛强度和对日常活动干扰的得分均为6.2。SATMED-Q测试的总体评分为47.3/100，比西班牙人群的标准化得分低1.4分。
根据NP4测试，神经性疼痛在西班牙基层医疗环境中高度流行。使用非甾体抗炎药和非阿片类镇痛药对这些患者进行治疗并不合适，因为不推荐将其用于此类疼痛。尽管他们使用了超过2种镇痛药进行治疗，但仍表示疼痛强度高、日常活动受到干扰，且对治疗的总体评价较低。
